Premium
Spruce Biosciences Inc (SPRB)
NASDAQ
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| Ikarian Capital, LLC | Institution | 121 356 | 4,49% | US$ 5,95M | 2026-04-30 |
| Ikarian Healthcare Master Fund, L.P. | Institution | 121 356 | 4,49% | US$ 5,95M | 2026-04-30 |
| Millennium Management LLC | Institution | 111 888 | 4,14% | US$ 5,49M | 2026-03-31 |
| Integrated Core Strategies (US) LLC | Institution | 103 026 | 3,81% | US$ 5,05M | 2026-03-24 |
| Citadel Advisors LLC | Institution | 70 065 | 2,59% | US$ 3,44M | 2026-03-31 |
| Squadron Master Fund LP | Institution | 70 000 | 2,59% | US$ 3,43M | 2026-03-24 |
| Peter Boone | Initiés | 68 184 | 2,52% | US$ 3,34M | 2025-11-21 |
| ADAR1 Capital Management, LLC | Institution | 58 600 | 2,17% | US$ 2,87M | 2026-03-31 |
| Alyeska Investment Group, L.P. | Institution | 51 671 | 1,91% | US$ 2,53M | 2026-03-31 |
| Wellington Management Group LLP | Institution | 48 796 | 1,81% | US$ 2,39M | 2026-03-31 |
| Boothbay Fund Management, LLC | Institution | 42 080 | 1,56% | US$ 2,06M | 2026-03-31 |
| Balyasny Asset Management L.P. | Institution | 40 000 | 1,48% | US$ 1,96M | 2026-03-31 |
| Abingworth LLP | Institution | 38 620 | 1,43% | US$ 1,89M | 2026-03-31 |
| Abingworth Bioventures VII LP | Institution | 38 620 | 1,43% | US$ 1,89M | 2026-02-18 |
| Armistice Capital LLC | Institution | 28 923 | 1,07% | US$ 1,42M | 2025-04-01 |
| Armistice Capital Master Fund Ltd. | Institution | 28 923 | 1,07% | US$ 1,42M | 2025-04-01 |
| Odlander, Fredrikson & Co. AB | Institution | 27 201 | 1,01% | US$ 1,33M | 2025-10-07 |
| HealthCap VIII, L.P. | Institution | 27 201 | 1,01% | US$ 1,33M | 2025-10-07 |
| Quinn Opportunity Partners LLC | Institution | 26 810 | 0,99% | US$ 1,32M | 2026-03-31 |
| ExodusPoint Capital Management, LP | Institution | 22 000 | 0,81% | US$ 1,08M | 2026-04-27 |
| Exoduspoint Partners Master Fund, LP | Institution | 22 000 | 0,81% | US$ 1,08M | 2026-04-27 |
| Dr. Javier Szwarcberg | Initiés | 19 004 | 0,70% | US$ 932,15k | 2026-03-24 |
| Vanguard Capital Management, LLC | Institution | 18 337 | 0,68% | US$ 899,43k | 2026-03-31 |
| BlackRock, Inc. | Institution | 16 938 | 0,63% | US$ 830,81k | 2026-03-31 |
| RiverVest Venture Management LLC | Institution | 15 580 | 0,58% | US$ 764,20k | 2025-01-07 |
| Geode Capital Management, LLC | Institution | 12 889 | 0,48% | US$ 632,21k | 2026-03-31 |
| Squadron Capital Management Llc | Institution | 12 200 | 0,45% | US$ 598,41k | 2026-03-31 |
| Diadema Partners LP | Institution | 10 000 | 0,37% | US$ 490,50k | 2026-03-31 |
| RiverVest Venture Fund III LP | Institution | 8 543 | 0,32% | US$ 419,03k | 2025-01-07 |
| Mr. Samir Gharib | Initiés | 8 263 | 0,31% | US$ 405,30k | 2026-03-24 |
| Rivervest Venture Fund IV, L.P. | Institution | 7 038 | 0,26% | US$ 345,21k | 2025-01-07 |
| StemPoint Capital LP | Institution | 6 360 | 0,24% | US$ 311,96k | 2026-03-31 |
| Vanguard Fiduciary Trust Company | Institution | 5 514 | 0,20% | US$ 270,46k | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 5 506 | 0,20% | US$ 270,07k | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 5 400 | 0,20% | US$ 264,87k | 2026-03-31 |
| Resolute Capital Asset Partners LLC | Institution | 4 000 | 0,15% | US$ 196,20k | 2026-03-31 |
| UBS Asset Management AG | Institution | 3 919 | 0,15% | US$ 192,23k | 2026-03-31 |
| Persistent Asset Partners Limited | Institution | 2 528 | 0,09% | US$ 124,00k | 2026-03-31 |
| Dr. Ralph Charlton | Initiés | 2 151 | 0,08% | US$ 105,51k | 2025-04-01 |
| Morgan Stanley | Institution | 1 415 | 0,05% | US$ 69,41k | 2026-03-31 |
| Dr. Kirk Ways | Initiés | 1 250 | 0,05% | US$ 61,31k | 2026-03-24 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
